NASDAQ:GDRX GoodRx (GDRX) Stock Price, News & Analysis $6.91 -0.17 (-2.40%) (As of 09/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get GoodRx alerts: Email Address About GoodRx Stock (NASDAQ:GDRX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GoodRx alerts:Sign Up Key Stats Today's Range$6.88▼$7.1150-Day Range$6.78▼$9.0552-Week Range$4.14▼$9.26Volume1.49 million shsAverage Volume1.45 million shsMarket Capitalization$2.59 billionP/E RatioN/ADividend YieldN/APrice Target$9.36Consensus RatingModerate Buy Company OverviewGoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.Read More… Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… GoodRx Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 60th PercentileGoodRx scored higher than 60% of companies evaluated by MarketBeat, and ranked 462nd out of 1,006 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingGoodRx has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 9 buy ratings, 4 hold ratings, and 1 sell rating.Amount of Analyst CoverageGoodRx has only been the subject of 4 research reports in the past 90 days.Read more about GoodRx's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth53.33% Earnings GrowthEarnings for GoodRx are expected to grow by 53.33% in the coming year, from $0.15 to $0.23 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of GoodRx is -690.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of GoodRx is -690.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioGoodRx has a PEG Ratio of 3.55. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGoodRx has a P/B Ratio of 3.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about GoodRx's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted11.11% of the float of GoodRx has been sold short.Short Interest Ratio / Days to CoverGoodRx has a short interest ratio ("days to cover") of 6.6.Change versus previous monthShort interest in GoodRx has recently increased by 9.99%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGoodRx does not currently pay a dividend.Dividend GrowthGoodRx does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted11.11% of the float of GoodRx has been sold short.Short Interest Ratio / Days to CoverGoodRx has a short interest ratio ("days to cover") of 6.6.Change versus previous monthShort interest in GoodRx has recently increased by 9.99%, indicating that investor sentiment is decreasing significantly. News and Social Media1.8 / 5News Sentiment0.32 News SentimentGoodRx has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for GoodRx this week, compared to 6 articles on an average week.Search InterestOnly 1 people have searched for GDRX on MarketBeat in the last 30 days. This is a decrease of -91% compared to the previous 30 days.MarketBeat Follows5 people have added GoodRx to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, GoodRx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $83,921.00 in company stock.Percentage Held by InsidersOnly 4.17% of the stock of GoodRx is held by insiders.Percentage Held by Institutions63.77% of the stock of GoodRx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about GoodRx's insider trading history. Receive GDRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GoodRx and its competitors with MarketBeat's FREE daily newsletter. Email Address GDRX Stock News HeadlinesGoodRx Holdings, Inc. (NASDAQ:GDRX) Major Shareholder Sells $83,921.22 in StockSeptember 4, 2024 | insidertrades.comShort Interest in GoodRx Holdings, Inc. (NASDAQ:GDRX) Rises By 10.0%September 18 at 9:53 PM | americanbankingnews.comForget Trump and KamalaForget Trump and Kamala. I don't care who you vote for - This calendar is the only thing that matters right now.September 20, 2024 | Investors Alley (Ad)Analysts Set GoodRx Holdings, Inc. (NASDAQ:GDRX) Target Price at $9.36September 16, 2024 | americanbankingnews.comFinancial Review: GoodRx (NASDAQ:GDRX) and HeartCore Enterprises (NASDAQ:HTCR)September 14, 2024 | americanbankingnews.comBuy Rating Affirmed: GoodRx’s Strategic Initiatives Promising Market Expansion and GrowthSeptember 9, 2024 | markets.businessinsider.comWhy Big Pharma is betting on telehealth strategiesSeptember 6, 2024 | finance.yahoo.comGoodRx Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)August 16, 2024 | benzinga.comSee More Headlines GDRX Stock Analysis - Frequently Asked Questions How have GDRX shares performed this year? GoodRx's stock was trading at $6.70 on January 1st, 2024. Since then, GDRX shares have increased by 3.1% and is now trading at $6.91. View the best growth stocks for 2024 here. How were GoodRx's earnings last quarter? GoodRx Holdings, Inc. (NASDAQ:GDRX) released its earnings results on Thursday, August, 8th. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by $0.01. The firm's revenue was up 5.7% on a year-over-year basis. When did GoodRx IPO? GoodRx (GDRX) raised $900 million in an initial public offering on Wednesday, September 23rd 2020. The company issued 34,600,000 shares at $24.00-$28.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan and Barclays acted as the underwriters for the IPO and BofA Securities, Citigroup, Credit Suisse, RBC Capital Markets, UBS Investment Bank, Cowen, Deutsche Bank Securities, Evercore ISI, Citizens Capital Markets, KKR, LionTree, Raymond James, SVB Leerink, Academy Securities, Loop Capital Markets, R. Seelaus and Ramirez were co-managers. Who are GoodRx's major shareholders? Top institutional shareholders of GoodRx include Millennium Management LLC (1.10%), Rubric Capital Management LP (1.00%), Renaissance Technologies LLC (0.79%) and American Century Companies Inc. (0.62%). Insiders that own company stock include Scott Wagner, Equity Vii LP Spectrum, Idea Men, Llc, Abdiel Capital Management, Llc, Trevor Bezdek, Babak Azad, Karsten Voermann, Bansi Nagji, Andrew Slutsky and Douglas Joseph Hirsch. View institutional ownership trends. How do I buy shares of GoodRx? Shares of GDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of GoodRx own? Based on aggregate information from My MarketBeat watchlists, some other companies that GoodRx investors own include Gilead Sciences (GILD), NVIDIA (NVDA), AbbVie (ABBV), Bristol-Myers Squibb (BMY), DraftKings (DKNG), GW Pharmaceuticals (GWPH) and Rocket Companies (RKT). Company Calendar Last Earnings8/08/2024Today9/20/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Data processing & preparation Sub-IndustryBusiness Services Current SymbolNASDAQ:GDRX CUSIPN/A CIK1809519 Webwww.goodrx.com Phone855-268-2822FaxN/AEmployees950Year FoundedN/APrice Target and Rating Average Stock Price Target$9.36 High Stock Price Target$16.00 Low Stock Price Target$4.50 Potential Upside/Downside+34.2%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage15 Analysts Profitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E Ratio46.47 P/E Growth3.55Net Income$-8,870,000.00 Net Margins-7.57% Pretax Margin-7.65% Return on Equity3.63% Return on Assets1.72% Debt Debt-to-Equity Ratio0.96 Current Ratio7.32 Quick Ratio7.32 Sales & Book Value Annual Sales$775.09 million Price / Sales3.37 Cash Flow$0.38 per share Price / Cash Flow18.14 Book Value$1.93 per share Price / Book3.61Miscellaneous Outstanding Shares375,205,000Free Float359,559,000Market Cap$2.62 billion OptionableOptionable Beta1.38 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NASDAQ:GDRX) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoodRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.